Brian Wilson


Image: Brian  Wilson

Brian Wilson has been covering biotech stocks for two years, and has been published extensively in the online investment community. He founded Bio-Wire in 2012 to provide a more streamlined content platform for biotech investors, and continues to provide high-level content. Prior to this, Wilson worked in the life sciences industry and attended Vanderbilt University.

Recent Quotes

"NBS is on track for its phase 2, AMR-001 data release in 2014."

— Brian Wilson, Seeking Alpha (12/19/13)
more >

Due to permission requirements, not all quotes are shown.